VanEck Pharmaceutical ETF
Price through Oct 6, 2026 · Flows through Oct 5, 2026. Figures use the latest available records, not a live quote. Fund details retrieved Oct 6, 2026. Holdings snapshot retrieved Oct 6, 2026.
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
SOURCE: MARKET TAPE & DAILY CREATION/REDEMPTION RECORDS · 1M SHOWN · NET +$22M OVER THIS RANGE
Money keeps arriving — +$22M of net inflows over the past month, about 2.2% of the fund's asset base, while the price has returned +4.8% so far this year. At 0.36% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | LLYELI LILLY | 20.69% | $1157.49 | +1.3% | ||
| 2 | MRKMERCK & CO | 13.39% | $141.94 | +1.7% | ||
| 3 | NVONOVO NORDISK A S | 5.58% | $37.53 | -0.0% | ||
| 4 | PFEPFIZER | 5.09% | $27.50 | +0.3% | ||
| 5 | TEVATEVA PHARMACEUTICAL | 4.80% | $39.13 | -1.3% | ||
| 6 | MCKMCKESSON | 4.63% | $921.67 | +0.7% | ||
| 7 | BMYBRISTOL MYERS SQUIBB | 4.83% | $59.59 | +1.3% | ||
| 8 | CORCENCORA INC | 4.38% | $316.37 | +0.5% | ||
| 9 | GSKGSK | 4.43% | $46.60 | +0.1% | ||
| 10 | ABBVABBVIE | 3.69% | $266.69 | +0.3% | ||
| 11 | HLNHALEON | 3.65% | $8.87 | +0.6% | ||
| 12 | NVSNOVARTIS AG | 3.61% | $140.79 | -0.1% | ||
| 13 | AZNASTRAZENECA | 3.52% | $158.61 | +1.3% | ||
| 14 | JNJJOHNSON & JOHNSON | 3.38% | $254.78 | +0.7% | ||
| 15 | SNYSANOFI | 3.28% | $39.56 | +0.1% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus CSV export, watchlists, and flow alerts — unlock across the network.
Sign in to see all 27| 1 week | -1.2% |
| 1 month | -5.3% |
| 3 months | -1.6% |
| 6 months | +3.8% |
| YTD | +4.8% |
| 1 year | +15.4% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | +$6M |
| 1 month | +$22M |
| 3 months | +$124M |
| YTD | −$296M |
| 1 year | +$308M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
The top holding is 20.7% of the book; the top ten carry 72%. Spread across 25+ names, it behaves like roughly 12 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| LLY ELI LILLY | $48M | $46M |
| ABBV ABBVIE | $4M | $4M |
| JNJ JOHNSON & JOHNSON | $3M | $4M |
| BMY BRISTOL MYERS SQUIBB | $1M | $5M |
| NVO NOVO NORDISK A S | $2M | $4M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat PPH on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| SPDW State Street SPDR Portfolio Developed World ex-US ETF | 0.03% | $41B | +$286M | -33bp on fee · 41× the assets · +$286M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.4B | +$199M | -33bp on fee · 18× the assets · +$199M in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $32.4B | +$497M | -32bp on fee · 32× the assets · +$497M in over the month | Head-to-head |
| IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.04% | $23.3B | +$575M | -32bp on fee · 23× the assets · +$575M in over the month | Head-to-head |
| IGIB iShares 5-10 Year Investment Grade Corporate Bond ETF | 0.04% | $18.6B | +$412M | -32bp on fee · 18× the assets · +$412M in over the month | Head-to-head |